Adverse events should be reported

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Mylan by phone: 0800 121 8267 or by email: ukpharmacovigilance@mylan.com

Sirdupla is a twice-daily treatment for moderate to severe asthma

Sirdupla is a maintenance inhaler and is manufactured in the UK by 3M

You should use your Sirdupla inhaler twice every day

Sirdupla helps open airways and reduce lung inflammation caused by asthma

Sirdupla is a different type of treatment to your rescue inhaler

Why Sirdupla?

You have been prescribed Sirdupla by your doctor to help treat and prevent symptoms of asthma.

Sirdupla is a type of maintenance inhaler. A maintenance inhaler is designed for daily, long-term treatment of asthma rather than short-term symptom relief. Any sudden symptoms should be treated with a rescue (reliever) inhaler.1,2

You should use Sirdupla every day, even if you don’t have symptoms.

How does Sirdupla work?

When you use your Sirdupla inhaler device two medications, salmeterol xinafoate and fluticasone propionate, enter your lungs and get to work.1,2

Fluticasone propionate

is a type of medication called a corticosteroid

It reduces swelling and irritation in the lungs

Salmeterol xinafoate

is a type of medication called a long-acting bronchodilator – it lasts for at least 12 hours which is why it should be taken twice daily

It helps the airways in the lungs stay open, making it easier for air to get in and out

  • Find out more about Sirdupla

    Take a look at this guide to Sirdupla

    For additional supportive information about Sirdupla while you’re on the go, take a copy of this leaflet with you. It covers all the key points you need to know about using Sirdupla.

  • Read the Patient Information Leaflet

    You can find further details about your Sirdupla inhaler – including instructions for use, possible side effects and how to store the device – in the Patient Information Leaflet (PIL). This will have been included in the box with your inhaler.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Mylan by phone: 0800 121 8267 or by email: ukpharmacovigilance@mylan.com